Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

PHAT.US Logo

PHAT.US - Current Price

$14.47

Company Information

▼
Company Name
Phathom Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US71722W1071
CIK: 0001783183
CUSIP: 71722W107
Currency: USD
Full Time Employees: 427
Phone: 877 742 8466
Website: https://www.phathompharma.com
Fiscal Year End: December
IPO Date: Oct 25, 2019
Description:

Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

Address:

100 Campus Drive, Florham Park, NJ, United States, 07932

Directors & Officers

▼
Name Title Year Born
Mr. David A. Socks Co-Founder 1975
Dr. Azmi Nabulsi M.D., M.P.H. Co-Founder 1959
Mr. Steven L. Basta M.B.A. CEO, President & Director 1966
Mr. Sanjeev Narula Chief Financial & Business Officer 1961
Mr. Jonathan Bentley Senior VP and Head of Sales, Operations & Training NA
Mr. Robert Breedlove VP of Finance & Principal Accounting Officer NA
Mr. Eric Sciorilli Director of Business Development & Investor Relations NA
Mr. Bill Aprea J.D. Senior VP, Chief Compliance Officer & Deputy Chief Legal Officer NA
Ms. Anne Marie Cook Esq., J.D. Chief Legal Officer & Corporate Secretary 1962
Ms. Nancy R. Phelan Senior Vice President of Marketing & Analytics 1969

Shares Statistics

▼
Shares Outstanding: 78.01M
Shares Float: 50.69M
% Insiders: 514.80%
% Institutions: 8,832.50%
Short % Float: 24.98%

Valuation Metrics

▼
Enterprise Value: $1.20B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $1.13B
EBITDA: $-212.78M
Book Value: $-5.95
Earnings/Share: $-3.76
Profit Margin: -186.53%
Operating Margin: -30.85%
ROA (TTM): -42.54%
ROE (TTM): -3,489.00%
Revenue (TTM): $147.19M
Revenue/Share (TTM): $2.04
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 202.70%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Mar 31, 2026 0.00 -0.39 N/A 10,000.00%
Dec 31, 2025 0.00 -0.42 N/A 10,000.00%
Sep 30, 2025 -0.15 -0.47 N/A 6,808.51%
Jun 30, 2025 -0.79 -0.91 N/A 1,318.68%
Mar 31, 2025 -1.07 -1.07 N/A -37.52%
Dec 31, 2024 -1.05 -1.08 N/A 277.78%
Sep 30, 2024 -1.32 -1.49 N/A 1,140.94%
Jun 30, 2024 -1.56 -1.38 N/A -1,304.35%
Mar 31, 2024 -1.42 -1.31 N/A -839.69%
Dec 31, 2023 -1.39 -1.08 N/A -2,870.37%
Sep 30, 2023 -0.76 -0.89 N/A 1,460.67%
Jun 30, 2023 -0.84 -0.98 N/A 1,428.57%
Mar 31, 2023 -0.89 -1.26 N/A 2,936.51%
Dec 31, 2022 -1.33 -1.35 N/A 148.15%
Sep 30, 2022 -1.32 -1.32 N/A 0.00%
Jun 30, 2022 -1.33 -1.03 N/A -2,912.62%
Mar 31, 2022 -1.07 -0.97 N/A -1,030.93%
Dec 31, 2021 -0.95 -1.03 N/A 776.70%
Sep 30, 2021 -0.98 -0.98 N/A 0.00%
Jun 30, 2021 -1.00 -1.07 N/A 654.21%
Mar 31, 2021 -0.96 -1.19 N/A 1,932.77%
Dec 31, 2020 -1.58 -1.01 N/A -5,643.56%
Sep 30, 2020 -1.02 -0.67 N/A -5,223.88%
Jun 30, 2020 -0.64 -0.56 N/A -1,428.57%
Mar 31, 2020 -0.62 -0.72 N/A 1,388.89%
Dec 31, 2019 -3.97 -1.25 N/A -21,760.00%
Sep 30, 2019 -9.30 -1.14 N/A -71,578.95%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $297.26M $N/A $378.32M $631.90M $-253.58M
2023-12-31 $381.39M $N/A $413.84M $486.60M $-72.76M
2022-12-31 $155.39M $N/A $164.81M $239.62M $-74.81M
2021-12-31 $183.26M $N/A $189.43M $117.28M $72.16M
2020-12-31 $287.50M $N/A $295.11M $100.84M $194.27M
2019-12-31 $243.77M $N/A $257.18M $29.22M $227.96M
2018-12-31 $879.00K $N/A $902.00K $2.19M $-1.29M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 05, 2025 N/A N/A N/A N/A N/A N/A
Jul 16, 2025 N/A N/A N/A N/A N/A N/A
May 21, 2025 N/A N/A N/A N/A N/A N/A
May 06, 2025 N/A N/A N/A N/A N/A N/A
Apr 07, 2025 N/A N/A N/A N/A N/A N/A
Jan 21, 2025 N/A N/A N/A N/A N/A N/A
Jan 21, 2025 N/A N/A N/A N/A N/A N/A
Jan 21, 2025 N/A N/A N/A N/A N/A N/A
Dec 19, 2024 N/A N/A N/A N/A N/A N/A
Dec 19, 2024 N/A N/A N/A N/A N/A N/A
Dec 13, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist